Cadmium in PDB 4bl2: Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa
Enzymatic activity of Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa
All present enzymatic activity of Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa:
3.4.16.4;
Protein crystallography data
The structure of Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa, PDB code: 4bl2
was solved by
L.H.Otero,
A.Rojas-Altuve,
J.A.Hermoso,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
19.89 /
2.72
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
81.437,
101.637,
186.838,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
20.67 /
28.67
|
Other elements in 4bl2:
The structure of Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa also contains other interesting chemical elements:
Cadmium Binding Sites:
The binding sites of Cadmium atom in the Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa
(pdb code 4bl2). This binding sites where shown within
5.0 Angstroms radius around Cadmium atom.
In total 7 binding sites of Cadmium where determined in the
Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa, PDB code: 4bl2:
Jump to Cadmium binding site number:
1;
2;
3;
4;
5;
6;
7;
Cadmium binding site 1 out
of 7 in 4bl2
Go back to
Cadmium Binding Sites List in 4bl2
Cadmium binding site 1 out
of 7 in the Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa
Mono view
Stereo pair view
|
A full contact list of Cadmium with other atoms in the Cd binding
site number 1 of Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cd1001
b:46.5
occ:1.00
|
OE2
|
A:GLU145
|
2.3
|
43.9
|
1.0
|
CL
|
A:CL1010
|
2.4
|
43.8
|
1.0
|
OE2
|
B:GLU145
|
2.4
|
42.9
|
1.0
|
ND1
|
A:HIS143
|
2.4
|
41.5
|
1.0
|
OE1
|
B:GLU145
|
2.7
|
42.3
|
1.0
|
CD
|
B:GLU145
|
2.9
|
41.0
|
1.0
|
O
|
A:HOH2049
|
2.9
|
36.0
|
1.0
|
CD
|
A:GLU145
|
3.2
|
44.0
|
1.0
|
CE1
|
A:HIS143
|
3.4
|
42.0
|
1.0
|
CG
|
A:HIS143
|
3.5
|
41.5
|
1.0
|
CB
|
A:HIS143
|
3.7
|
41.2
|
1.0
|
CG
|
A:GLU145
|
3.8
|
44.3
|
1.0
|
CD
|
B:CD1002
|
3.8
|
45.1
|
1.0
|
OD1
|
A:ASN307
|
4.1
|
64.1
|
1.0
|
OE1
|
A:GLU145
|
4.2
|
44.5
|
1.0
|
CG2
|
A:VAL302
|
4.4
|
36.9
|
1.0
|
O
|
B:ILE144
|
4.4
|
41.8
|
1.0
|
ND1
|
B:HIS143
|
4.4
|
45.1
|
1.0
|
CG
|
B:GLU145
|
4.4
|
38.6
|
1.0
|
NE2
|
A:HIS143
|
4.6
|
43.1
|
1.0
|
CD2
|
A:HIS143
|
4.6
|
42.6
|
1.0
|
CG
|
B:HIS143
|
4.9
|
44.8
|
1.0
|
CE1
|
B:HIS143
|
4.9
|
45.3
|
1.0
|
OG1
|
A:THR300
|
5.0
|
36.6
|
1.0
|
|
Cadmium binding site 2 out
of 7 in 4bl2
Go back to
Cadmium Binding Sites List in 4bl2
Cadmium binding site 2 out
of 7 in the Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa
Mono view
Stereo pair view
|
A full contact list of Cadmium with other atoms in the Cd binding
site number 2 of Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cd1003
b:47.4
occ:1.00
|
OD1
|
A:ASP209
|
2.3
|
51.2
|
1.0
|
O
|
B:GLY135
|
2.3
|
32.4
|
1.0
|
OD2
|
A:ASP209
|
2.5
|
51.3
|
1.0
|
CL
|
B:CL1012
|
2.6
|
51.9
|
1.0
|
CG
|
A:ASP209
|
2.7
|
51.6
|
1.0
|
NE2
|
B:HIS311
|
3.1
|
41.2
|
1.0
|
C
|
B:GLY135
|
3.4
|
31.3
|
1.0
|
NE2
|
B:GLN137
|
3.5
|
34.2
|
1.0
|
CD2
|
B:HIS311
|
3.6
|
41.2
|
1.0
|
CA
|
B:GLY135
|
3.9
|
31.3
|
1.0
|
CE1
|
B:HIS311
|
4.2
|
42.9
|
1.0
|
CB
|
A:ASP209
|
4.2
|
52.5
|
1.0
|
CD
|
B:GLN137
|
4.3
|
35.3
|
1.0
|
N
|
B:MET136
|
4.6
|
47.6
|
1.0
|
CG
|
B:HIS311
|
4.8
|
43.2
|
1.0
|
OG1
|
A:THR210
|
4.9
|
30.7
|
1.0
|
CB
|
A:GLN207
|
4.9
|
57.7
|
1.0
|
OE1
|
B:GLN137
|
5.0
|
36.3
|
1.0
|
|
Cadmium binding site 3 out
of 7 in 4bl2
Go back to
Cadmium Binding Sites List in 4bl2
Cadmium binding site 3 out
of 7 in the Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa
Mono view
Stereo pair view
|
A full contact list of Cadmium with other atoms in the Cd binding
site number 3 of Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cd1004
b:0.1
occ:1.00
|
CE1
|
A:HIS232
|
2.4
|
91.2
|
1.0
|
ND1
|
A:HIS232
|
3.3
|
89.2
|
1.0
|
NE2
|
A:HIS232
|
3.4
|
91.9
|
1.0
|
O
|
A:LYS229
|
4.3
|
55.5
|
1.0
|
CG
|
A:HIS232
|
4.5
|
88.6
|
1.0
|
CD2
|
A:HIS232
|
4.5
|
90.3
|
1.0
|
O
|
A:LYS230
|
4.6
|
96.8
|
1.0
|
|
Cadmium binding site 4 out
of 7 in 4bl2
Go back to
Cadmium Binding Sites List in 4bl2
Cadmium binding site 4 out
of 7 in the Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa
Mono view
Stereo pair view
|
A full contact list of Cadmium with other atoms in the Cd binding
site number 4 of Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cd1005
b:48.3
occ:1.00
|
OD1
|
B:ASP209
|
2.3
|
46.2
|
1.0
|
O
|
A:GLY135
|
2.4
|
37.6
|
1.0
|
CL
|
A:CL1011
|
2.5
|
40.0
|
1.0
|
OD2
|
B:ASP209
|
2.6
|
45.9
|
1.0
|
CE1
|
A:HIS311
|
2.8
|
45.7
|
1.0
|
CG
|
B:ASP209
|
2.8
|
46.2
|
1.0
|
C
|
A:GLY135
|
3.4
|
35.8
|
1.0
|
ND1
|
A:HIS311
|
3.5
|
45.3
|
1.0
|
CA
|
A:GLY135
|
3.8
|
35.0
|
1.0
|
NE2
|
A:HIS311
|
3.9
|
45.8
|
1.0
|
NE2
|
A:GLN137
|
4.0
|
42.8
|
1.0
|
CB
|
B:ASP209
|
4.3
|
47.0
|
1.0
|
CG
|
A:GLN137
|
4.4
|
42.1
|
1.0
|
CD
|
A:GLN137
|
4.4
|
42.4
|
1.0
|
N
|
A:MET136
|
4.6
|
43.8
|
1.0
|
CG
|
A:HIS311
|
4.8
|
45.6
|
1.0
|
NH2
|
A:ARG110
|
4.8
|
62.6
|
1.0
|
CD2
|
A:HIS311
|
4.9
|
45.9
|
1.0
|
CB
|
B:GLN207
|
5.0
|
58.3
|
1.0
|
|
Cadmium binding site 5 out
of 7 in 4bl2
Go back to
Cadmium Binding Sites List in 4bl2
Cadmium binding site 5 out
of 7 in the Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa
Mono view
Stereo pair view
|
A full contact list of Cadmium with other atoms in the Cd binding
site number 5 of Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cd1002
b:45.1
occ:1.00
|
OE1
|
A:GLU145
|
2.1
|
44.5
|
1.0
|
ND1
|
B:HIS143
|
2.2
|
45.1
|
1.0
|
OE2
|
A:GLU145
|
2.3
|
43.9
|
1.0
|
CL
|
B:CL1009
|
2.5
|
34.7
|
1.0
|
CD
|
A:GLU145
|
2.5
|
44.0
|
1.0
|
OE2
|
B:GLU145
|
2.7
|
42.9
|
1.0
|
CE1
|
B:HIS143
|
3.2
|
45.3
|
1.0
|
CG
|
B:HIS143
|
3.2
|
44.8
|
1.0
|
CD
|
B:GLU145
|
3.3
|
41.0
|
1.0
|
CB
|
B:HIS143
|
3.5
|
44.4
|
1.0
|
CD
|
A:CD1001
|
3.8
|
46.5
|
1.0
|
CG
|
B:GLU145
|
3.8
|
38.6
|
1.0
|
OE1
|
B:GLU145
|
4.0
|
42.3
|
1.0
|
CG
|
A:GLU145
|
4.0
|
44.3
|
1.0
|
ND1
|
A:HIS143
|
4.3
|
41.5
|
1.0
|
NE2
|
B:HIS143
|
4.4
|
45.9
|
1.0
|
CD2
|
B:HIS143
|
4.4
|
45.4
|
1.0
|
CG2
|
B:VAL302
|
4.6
|
39.1
|
1.0
|
OD1
|
B:ASN307
|
4.8
|
68.0
|
1.0
|
CE1
|
A:HIS143
|
4.8
|
42.0
|
1.0
|
OG1
|
B:THR300
|
4.8
|
36.7
|
1.0
|
CG
|
A:HIS143
|
4.9
|
41.5
|
1.0
|
CB
|
A:GLU145
|
4.9
|
45.5
|
1.0
|
CA
|
B:HIS143
|
4.9
|
44.4
|
1.0
|
|
Cadmium binding site 6 out
of 7 in 4bl2
Go back to
Cadmium Binding Sites List in 4bl2
Cadmium binding site 6 out
of 7 in the Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa
Mono view
Stereo pair view
|
A full contact list of Cadmium with other atoms in the Cd binding
site number 6 of Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cd1006
b:0.6
occ:1.00
|
NE2
|
B:HIS232
|
2.5
|
80.8
|
1.0
|
CE1
|
B:HIS232
|
3.0
|
78.4
|
1.0
|
CD2
|
B:HIS232
|
3.7
|
72.9
|
1.0
|
ND1
|
B:HIS232
|
4.3
|
70.5
|
1.0
|
CG
|
B:HIS232
|
4.6
|
67.2
|
1.0
|
|
Cadmium binding site 7 out
of 7 in 4bl2
Go back to
Cadmium Binding Sites List in 4bl2
Cadmium binding site 7 out
of 7 in the Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa
Mono view
Stereo pair view
|
A full contact list of Cadmium with other atoms in the Cd binding
site number 7 of Crystal Structure of PBP2A Clinical Mutant E150K From Mrsa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cd1007
b:75.4
occ:1.00
|
OD2
|
B:ASP573
|
2.6
|
48.9
|
1.0
|
OD1
|
B:ASN569
|
2.6
|
50.1
|
1.0
|
OD1
|
B:ASP573
|
2.7
|
55.3
|
1.0
|
CG
|
B:ASP573
|
3.0
|
51.3
|
1.0
|
O
|
B:HOH2101
|
3.1
|
35.3
|
1.0
|
CG
|
B:ASN569
|
3.8
|
49.3
|
1.0
|
O
|
B:HOH2100
|
4.0
|
43.9
|
1.0
|
ND2
|
B:ASN569
|
4.4
|
49.2
|
1.0
|
CB
|
B:ASP573
|
4.4
|
46.8
|
1.0
|
O
|
B:ASN569
|
4.8
|
48.1
|
1.0
|
NZ
|
B:LYS456
|
5.0
|
50.9
|
1.0
|
CB
|
B:ASN569
|
5.0
|
49.1
|
1.0
|
|
Reference:
J.Fishovitz,
A.Rojas-Altuve,
L.H.Otero,
M.Dawley,
C.Carrasco-Lopez,
M.Chang,
J.A.Hermoso,
S.Mobashery.
Disruption of Allosteric Response As An Unprecedented Mechanism of Resistance to Antibiotics. J.Am.Chem.Soc. V. 136 9814 2014.
ISSN: ISSN 0002-7863
PubMed: 24955778
DOI: 10.1021/JA5030657
Page generated: Fri Jul 19 16:58:56 2024
|